The relationship between pregnancy, HCS and B lymphocytes

Area of Science:

• Immunology
• Reproductive Biology
• Clinical Chemistry

Background:

• Pregnancy involves complex physiological changes affecting maternal immune function.
• Understanding immune cell dynamics and hormonal influences during gestation is crucial for maternal-fetal health.
• Previous research has indicated potential alterations in lymphocyte populations during pregnancy.

Purpose of the Study:

• To quantitatively assess lymphocyte subpopulations (B, T, null cells) in pregnant women.
• To measure serum concentrations of Human Chorionic Somatomammotropin (HCS) and key immune factors (immunoglobulins, complement components) during pregnancy.
• To compare these parameters between pregnant women and non-pregnant controls.

Main Methods:

• Venous blood samples were collected from 32 pregnant women across various stages.
• A control group of 7 non-pregnant women was included for comparison.
• Lymphocyte subpopulations were quantified, and serum levels of HCS, IgG, IgM, IgA, C4, and C1 inactivator were measured.

Main Results:

• A statistically significant decrease in the percentage of B lymphocytes was observed during pregnancy.
• This decline in B cell percentage was found to be directly associated with rising concentrations of Human Chorionic Somatomammotropin (HCS).
• No significant changes were detected in T cells, null cells, immunoglobulins (IgG, IgM, IgA), C4, or C1 inactivator levels.

Conclusions:

• Pregnancy is associated with a specific reduction in B lymphocyte numbers.
• The observed decrease in B cells appears to be hormonally regulated, linked to elevated HCS levels.
• Key humoral and cellular immune parameters, apart from B cells, remain relatively stable during pregnancy.